Physician profile
William E Sowers
NPI 1841378833
$2,453.95
in general payments reported to CMS, 2019-2025
18 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,257 · 2020: $334 · 2021: $444 · 2023: $37.29 · 2024: $212 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.33 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $731.75 | 2019-2024 | Airsupra |
| Pfizer INC. | $323.96 | 2019-2025 | |
| Amgen INC. | $188.18 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.75 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $162.61 | 2019-2021 | |
| Lilly USA, LLC | $143.38 | 2019-2021 | |
| Allergan, INC. | $127.50 | 2019-2020 | |
| Novo Nordisk INC | $94.86 | 2019-2025 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $81.72 | 2019 | |
| Glaxosmithkline, LLC. | $77.37 | 2019-2024 | Shingrix, Arexvy, Bexsero |
| Merck Sharp & Dohme LLC | $68.53 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Janssen Pharmaceuticals, INC | $53.54 | 2019-2021 | |
| Abbvie INC. | $48.74 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.89 | 2019 | |
| Sanofi-Aventis U.S. LLC | $41.65 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $34.77 | 2024-2025 | Intellis Adaptivestim, Venaseal |
| Boston Scientific Corporation | $27.07 | 2025 | Watchman Flx |
| Axonics, INC. | $14.68 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.